Ava martoma

Dr. rosemary a. martoma
What is mathew martoma doing now
Alexandra cohen

•

Husband Mathew Martoma is serving 9-year sentence.

By Raif Karerat

WASHINGTON, DC: Rosemary Martoma, the wife of former hedge fund manager Mathew Martoma, is battling the federal government to save her opulent lifestyle after her husband masterminded the most insidiously lucrative insider trading scheme in history.

Rosemary Martoma is fighting to block federal authorities from seizing her share of the family assets, including their $1.9 million Boca Raton, Florida mansion and $4 million stowed away in various bank accounts.

Matthew Martoma, once an SAC Capital hedge fund portfolio manager, was convicted last February of conspiracy and securities fraud.

USA Today reports that he surreptitiously traded non-public information about tests on an experimental Alzheimer’s disease drug being developed by pharmaceutical corporations Elan and Wyeth. He then utilized the test-results to “trigger a massive SAC Capital sell-off that generated $276 million in profits” while circumventing any losses. Due to his aspirations of white-collar crime, Matthew Martoma is currentl

•

The federal investigation echoed tactics used for the Mob: get low-level workers to inform on those farther up the hierarchy.Illustration by ConcepciÃ³n Studios. Clockwise from Top: Louis Lanzano / Bloomberg via Getty; Shannon Stapleton / Reuters / Corbis; Louis Lanzano/Bloomberg via Getty; Brendan McDermid / Reuters / Corbis; Spencer Platt / Getty; Ronda Churchill / Bloomberg via Getty

As Dr. Sid Gilman approached the stage, the hotel ballroom quieted with anticipation. It was July 29, 2008, and a thousand people had gathered in Chicago for the International Conference on Alzheimer’s Disease. For decades, scientists had tried, and failed, to devise a cure for Alzheimer’s. But in recent years two pharmaceutical companies, Elan and Wyeth, had worked together on an experimental drug called bapineuzumab, which had shown promise in halting the cognitive decay caused by the disease. Tests on mice had proved successful, and in an initial clinical trial a small number of human patients appeared to improve. A second phase of trials, involving two hundred and forty patients, was near

•

Academics praise insider trading suspect's past

Arrest puzzles academics who knew him, praised his ethics
Excelled at NIH, Duke, Stanford universities

BOSTON (AP) — Mathew Martoma knew from an early age he wanted to blend his interests in health care, business and law into a career, and he excelled as a bioethics student. Yet the 38-year-old Florida man now finds himself embroiled in what could prove one of the biggest ethical lapses in Wall Street's history.

Federal prosecutors allege Martoma, a former hedge fund portfolio manager, persuaded a medical professor to reveal secret data from an Alzheimer's disease drug trial. They say that allowed Martoma to engineer a record-setting insider-trading scheme that reaped more than a quarter-billion dollars in illegal profits.

The FBI arrested Martoma on Nov. 20 at his $2 million Palm Beach County home on two counts of securities fraud and a related conspiracy charge. His lawyer says there was no misuse of secret information. Phone calls by The Associated Press to listings for Martoma were not returned.

The arrest has surprised